Skip to main content
. 2021 Mar 29;2021(3):CD001689. doi: 10.1002/14651858.CD001689.pub4

1.8. Analysis.

1.8

Comparison 1: Antenatal (± postnatal) prophylaxis: Heparin (LMWH or UFH) versus no treatment/placebo, Outcome 8: Adverse effects not sufficient to stop treatment